Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI105901

Attempt to transfer contact hypersensitivity in man with dialysate of peripheral leukocytes

Michael W. Brandriss

1Department of Medicine, Rochester General Hospital and the University of Rochester School of Medicine and Dentistry, Rochester, New York 14621

Find articles by Brandriss, M. in: PubMed | Google Scholar

Published September 1, 1968 - More info

Published in Volume 47, Issue 9 on September 1, 1968
J Clin Invest. 1968;47(9):2152–2157. https://doi.org/10.1172/JCI105901.
© 1968 The American Society for Clinical Investigation
Published September 1, 1968 - Version history
View PDF
Abstract

In humans delayed hypersensitivity to tuberculin and coccidiodin can be transferred from a skin-test positive donor to a previously nonreactive recipient with a dialyzable fraction of donor peripheral leukocytes. The mechanism by which transfer is effected by this relatively low molecular weight material is unknown. Should transfer with dialysate be accomplished with hypersensitivity to low molecular weight artificial antigens, further characterization of “transfer factor” might be facilitated.

A maximal degree of contact sensitivity to a simple chemical, dinitrochlorobenzene, was produced in tuberculin-sensitive human volunteers, who were then used as donors. Seven of the eight donors reacted with 15 mm or more of induration to 0.1 μg of tuberculin, purified protein derivative, while recipients did not react to 5 μg. The dialyzable fraction of peripheral leukocytes from 500 ml of donor blood was injected into each of eight recipients in an attempt at simultaneous transfer of systemic sensitivity to both tuberculin and dinitrochlorobenzene. Transfer of tuberculin sensitivity was accomplished with four of seven dialysates from tuberculin-positive donors but in none of the eight attempts was contact sensitivity transferred with the same dialysates.

The results indicate that tuberculin sensitivity and contact type sensitivity to a simple chemical differ in respect to the behavior of transfer factor and that other models are necessary if dialyzable transfer factor is to be studied with nonbacterial antigens.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 2152
page 2152
icon of scanned page 2153
page 2153
icon of scanned page 2154
page 2154
icon of scanned page 2155
page 2155
icon of scanned page 2156
page 2156
icon of scanned page 2157
page 2157
Version history
  • Version 1 (September 1, 1968): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts